Lutetium-177 Dota Tetrazine
Lutetium-177 Dota Tetrazine - Related Videos
03:36
Pretargeted Radioimmunotherapy: A Method for Targeted Delivery of Therapeutic Radionuclides to Tumors
0 Views •
2023
This video describes the technique of pretargeted radioimmunotherapy or PRIT, in which immunoconjugates followed by radioligands are administered for treating tumors. This radioimmunotherapy reduces radiation doses to healthy tissues and utilizes radionuclides with very low half-lives incompatible with antibody-based vectors.
10:54
Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
0 Views •
Cited by 7 •
2017
Here, we describe a protocol for radiolabeling and in vivo testing of tridentate 99mTc(I) chelate-tetrazine derivatives for pre-targeting and bioorthogonal chemistry.
14:26
Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers (Diethylaminoethyl-cellulose Columns)
0 Views •
Cited by 3 •
2019
This method of trypanosome separation from blood depends on their surface charge being less negative than mammalian blood cells. Infected blood is placed and treated on an anion-exchanger column. This method, the most fitting diagnostic for African trypanosomiasis, provides purified parasites for immunological, biological, biochemical, pharmaceutical and molecular biology investigations.
02:31
Detection of Orexin and Cannabinoid Receptor Co-localization in Diet-Induced Obese Zebrafish
0 Views •
2025
This video demonstrates a protocol for investigating the co-localization of orexin and cannabinoid receptors in normal and diet-induced obesity (DIO) adult zebrafish brain tissue using immunofluorescence.
06:26
Repeated Orotracheal Intubation in Mice
0 Views •
Cited by 2 •
2020
The goal of this article is to describe a refined method of intubation of the laboratory mouse. The method is noninvasive and, therefore, ideal for studies that require serial monitoring of respiratory function and/or instillation of treatments into the lung.
FAQs
DOTA provides the coordination environment that retains Lu3+ within the conjugate. Its role is chemically distinct from that of tetrazine: the chelator manages metal binding, whereas tetrazine supplies the reactive handle for later coupling. Keeping these functions in one platform connects radionuclide incorporation with selective assembly of a targeted radioligand.
The tetrazine group reacts with trans-cyclooctene through an inverse-electron-demand Diels–Alder reaction. This pairing gives the platform a defined coupling event that is rapid, selective, and bioorthogonal. Because the reaction proceeds under mild conditions, it supports the staged chemical assembly required in pretargeted radiopharmaceutical workflows.
Linking the chelator and tetrazine creates a division of labor within the same radiochemical construct. Lu3+ coordination establishes the radionuclide-bearing component, while tetrazine remains available to recognize a trans-cyclooctene-modified partner. This architecture provides greater control over radioligand assembly than a design lacking a separately addressable coupling handle.
In a pretargeted strategy, the tumor-associated targeting agent is modified with trans-cyclooctene before the lutetium-177 conjugate is administered. The targeting agent and radionuclide-bearing component therefore function as separate chemical participants rather than being introduced as one assembled unit. This sequence supports controlled study of modular radiopharmaceutical design.
A basic workflow begins by preparing the tumor-associated targeting agent with a trans-cyclooctene group, followed by administration of the lutetium-177 DOTA tetrazine conjugate. The tetrazine then reacts with the installed trans-cyclooctene through the stated bioorthogonal cycloaddition. This order is central because targeting and radionuclide components are handled in separate stages.
Key requirements are the DOTA chelator for Lu3+, the tetrazine reaction site, and a trans-cyclooctene-bearing targeting agent. The coupling relies on a rapid, selective inverse-electron-demand Diels–Alder reaction under mild conditions. Together, these components define the assembly logic without requiring the targeting agent and radionuclide conjugate to be introduced as one molecule.
In chemistry research, this platform connects metal coordination, bioorthogonal reaction design, and radiopharmaceutical assembly. Its applications include studying pretargeted radionuclide therapy, targeted radioligand construction, and radiochemical design centered on lutetium-177. The framework is versatile because radionuclide binding and partner coupling are integrated in one construct but remain chemically distinct functions.